[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate

C169H258N26O36Si4 — CID 164983693

IUPAC[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESC=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)N2c3cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc3C(=O)N3CC4(CC4)C[C@H]3C2O)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO[Si](C)(C)C(C)(C)C)cc1)C(C)C
InChIInChI=1S/C53H85N7O10Si2.C47H69N7O10Si.C47H71N7O10Si.C22H33N5O6/c1-16-26-67-51(66)59-45(33(2)3)47(62)57-42(18-17-25-55-49(54)64)46(61)56-39-21-19-38(20-22-39)30-68-50(65)58-43-28-44(70-72(34(4)5,35(6)7)36(8)9)37(10)27-41(43)48(63)60-32-53(23-24-53)29-40(60)31-69-71(14,15)52(11,12)13;1-11-21-62-45(60)52-39(27(2)3)41(56)51-35(13-12-20-49-44(48)59)40(55)50-33-16-14-32(15-17-33)25-63-46(61)54-36-23-38(64-65(28(4)5,29(6)7)30(8)9)31(10)22-34(36)42(57)53-26-47(18-19-47)24-37(53)43(54)58;1-11-21-62-46(61)53-40(28(2)3)42(57)51-37(13-12-20-49-44(48)59)41(56)50-34-16-14-33(15-17-34)26-63-45(60)52-38-23-39(64-65(29(4)5,30(6)7)31(8)9)32(10)22-36(38)43(58)54-27-47(18-19-47)24-35(54)25-55;1-4-12-33-22(32)27-18(14(2)3)20(30)26-17(6-5-11-24-21(23)31)19(29)25-16-9-7-15(13-28)8-10-16/h16,19-22,27-28,33-36,40,42,45H,1,17-18,23-26,29-32H2,2-15H3,(H,56,61)(H,57,62)(H,58,65)(H,59,66)(H3,54,55,64);11,14-17,22-23,27-30,35,37,39,43,58H,1,12-13,18-21,24-26H2,2-10H3,(H,50,55)(H,51,56)(H,52,60)(H3,48,49,59);11,14-17,22-23,28-31,35,37,40,55H,1,12-13,18-21,24-27H2,2-10H3,(H,50,56)(H,51,57)(H,52,60)(H,53,61)(H3,48,49,59);4,7-10,14,17-18,28H,1,5-6,11-13H2,2-3H3,(H,25,29)(H,26,30)(H,27,32)(H3,23,24,31)/t40-,42-,45-;35?,37-,39-,43?;35-,37-,40-;17?,18-/m0000/s1
InChIKeyFVUGLUNCFIVNDY-ITNJRTJSSA-N
MW3342.41 g/mol
LogP25.03
Rot. Bonds78

About [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate

[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 164983693) has the molecular formula C169H258N26O36Si4 and a molecular weight of 3342.41 g/mol. Its IUPAC name is [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate.

Molecular Properties

Compound Name[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
PubChem CID164983693
Molecular FormulaC169H258N26O36Si4
Molecular Weight3342.41 g/mol
Exact Mass3339.82
IUPAC Name[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESC=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)N2c3cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc3C(=O)N3CC4(CC4)C[C@H]3C2O)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO[Si](C)(C)C(C)(C)C)cc1)C(C)C
InChIInChI=1S/C53H85N7O10Si2.C47H69N7O10Si.C47H71N7O10Si.C22H33N5O6/c1-16-26-67-51(66)59-45(33(2)3)47(62)57-42(18-17-25-55-49(54)64)46(61)56-39-21-19-38(20-22-39)30-68-50(65)58-43-28-44(70-72(34(4)5,35(6)7)36(8)9)37(10)27-41(43)48(63)60-32-53(23-24-53)29-40(60)31-69-71(14,15)52(11,12)13;1-11-21-62-45(60)52-39(27(2)3)41(56)51-35(13-12-20-49-44(48)59)40(55)50-33-16-14-32(15-17-33)25-63-46(61)54-36-23-38(64-65(28(4)5,29(6)7)30(8)9)31(10)22-34(36)42(57)53-26-47(18-19-47)24-37(53)43(54)58;1-11-21-62-46(61)53-40(28(2)3)42(57)51-37(13-12-20-49-44(48)59)41(56)50-34-16-14-33(15-17-34)26-63-45(60)52-38-23-39(64-65(29(4)5,30(6)7)31(8)9)32(10)22-36(38)43(58)54-27-47(18-19-47)24-35(54)25-55;1-4-12-33-22(32)27-18(14(2)3)20(30)26-17(6-5-11-24-21(23)31)19(29)25-16-9-7-15(13-28)8-10-16/h16,19-22,27-28,33-36,40,42,45H,1,17-18,23-26,29-32H2,2-15H3,(H,56,61)(H,57,62)(H,58,65)(H,59,66)(H3,54,55,64);11,14-17,22-23,27-30,35,37,39,43,58H,1,12-13,18-21,24-26H2,2-10H3,(H,50,55)(H,51,56)(H,52,60)(H3,48,49,59);11,14-17,22-23,28-31,35,37,40,55H,1,12-13,18-21,24-27H2,2-10H3,(H,50,56)(H,51,57)(H,52,60)(H,53,61)(H3,48,49,59);4,7-10,14,17-18,28H,1,5-6,11-13H2,2-3H3,(H,25,29)(H,26,30)(H,27,32)(H3,23,24,31)/t40-,42-,45-;35?,37-,39-,43?;35-,37-,40-;17?,18-/m0000/s1
InChIKeyFVUGLUNCFIVNDY-ITNJRTJSSA-N
XLogP25.03
TPSA871.34 Ų
H-Bond Donors25
H-Bond Acceptors36
Rotatable Bonds78
Heavy Atoms235
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003342.41
LogP ≤ 525.03
H-Bond Donors ≤ 525
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate?
The IUPAC name of [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate (CID 164983693) is [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate.
What is the SMILES notation for [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate?
The canonical SMILES for [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate is C=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)N2c3cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc3C(=O)N3CC4(CC4)C[C@H]3C2O)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO)cc1)C(C)C.C=CCOC(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(COC(=O)Nc2cc(O[Si](C(C)C)(C(C)C)C(C)C)c(C)cc2C(=O)N2CC3(CC3)C[C@H]2CO[Si](C)(C)C(C)(C)C)cc1)C(C)C.
What is the InChIKey of [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate?
The InChIKey is FVUGLUNCFIVNDY-ITNJRTJSSA-N. The full InChI is InChI=1S/C53H85N7O10Si2.C47H69N7O10Si.C47H71N7O10Si.C22H33N5O6/c1-16-26-67-51(66)59-45(33(2)3)47(62)57-42(18-17-25-55-49(54)64)46(61)56-39-21-19-38(20-22-39)30-68-50(65)58-43-28-44(70-72(34(4)5,35(6)7)36(8)9)37(10)27-41(43)48(63)60-32-53(23-24-53)29-40(60)31-69-71(14,15)52(11,12)13;1-11-21-62-45(60)52-39(27(2)3)41(56)51-35(13-12-20-49-44(48)59)40(55)50-33-16-14-32(15-17-33)25-63-46(61)54-36-23-38(64-65(28(4)5,29(6)7)30(8)9)31(10)22-34(36)42(57)53-26-47(18-19-47)24-37(53)43(54)58;1-11-21-62-46(61)53-40(28(2)3)42(57)51-37(13-12-20-49-44(48)59)41(56)50-34-16-14-33(15-17-34)26-63-45(60)52-38-23-39(64-65(29(4)5,30(6)7)31(8)9)32(10)22-36(38)43(58)54-27-47(18-19-47)24-35(54)25-55;1-4-12-33-22(32)27-18(14(2)3)20(30)26-17(6-5-11-24-21(23)31)19(29)25-16-9-7-15(13-28)8-10-16/h16,19-22,27-28,33-36,40,42,45H,1,17-18,23-26,29-32H2,2-15H3,(H,56,61)(H,57,62)(H,58,65)(H,59,66)(H3,54,55,64);11,14-17,22-23,27-30,35,37,39,43,58H,1,12-13,18-21,24-26H2,2-10H3,(H,50,55)(H,51,56)(H,52,60)(H3,48,49,59);11,14-17,22-23,28-31,35,37,40,55H,1,12-13,18-21,24-27H2,2-10H3,(H,50,56)(H,51,57)(H,52,60)(H,53,61)(H3,48,49,59);4,7-10,14,17-18,28H,1,5-6,11-13H2,2-3H3,(H,25,29)(H,26,30)(H,27,32)(H3,23,24,31)/t40-,42-,45-;35?,37-,39-,43?;35-,37-,40-;17?,18-/m0000/s1.
What are the key properties of [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate?
[4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate has a molecular weight of 3342.41 g/mol, XLogP of 25.03, 78 rotatable bonds, 25 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl (6aS)-6-hydroxy-2-methyl-11-oxo-3-tri(propan-2-yl)silyloxyspiro[6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-8,1'-cyclopropane]-5-carboxylate;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-3-methyl-2-(prop-2-enoxycarbonylamino)butanoyl]amino]pentanoyl]amino]phenyl]methyl N-[2-[(6S)-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamate;prop-2-enyl N-[(2S)-1-[[5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate;prop-2-enyl N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[2-[(6S)-6-(hydroxymethyl)-5-azaspiro[2.4]heptane-5-carbonyl]-4-methyl-5-tri(propan-2-yl)silyloxyphenyl]carbamoyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate is sourced from PubChem (CID 164983693), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).